Clincosm LogoSign in Get a demo

Lymphocytic Leukemia, Chronic

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphocytic Leukemia, Chronic Trial in Worldwide (Chlorambucil, Venetoclax, Obinutuzumab)

Active, not recruiting
Has Results
  • Lymphocytic Leukemia, Chronic
  • Duarte, California
  • +136 more
Dec 22, 2022

Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin Trial in Worldwide (BTCT4465A (Mosunetuzumab) IV, Atezolizumab, BTCT4465A

Recruiting
  • Lymphocytic Leukemia, Chronic
  • Lymphoma, Non Hodgkin
  • BTCT4465A (Mosunetuzumab) IV
  • +2 more
  • Duarte, California
  • +55 more
Aug 4, 2022

CAP-100 for Relapsed/Refractory Chronic Lymphocytic Leukemia

Recruiting
  • Lymphocytic Leukemia, Chronic
  • SLL
  • Durham, North Carolina
  • +1 more
Sep 16, 2021

Lymphocytic Leukemia, Chronic, Lymphoma, Small Lymphocytic Trial in Canada, United States (IPI-145 (duvelisib), Obinutuzumab)

Terminated
  • Lymphocytic Leukemia, Chronic
  • Lymphoma, Small Lymphocytic
  • La Jolla, California
  • +6 more
Mar 15, 2021

Lymphocytic Leukemia, Chronic Trial in United Kingdom, United States (Obinutuzumab, Venetoclax)

Completed
  • Lymphocytic Leukemia, Chronic
  • La Jolla, California
  • +9 more
Jan 7, 2020

Lymphocytic Leukemia, Chronic Trial in Russian Federation (Chlorambucil, Cyclophosphamide, Fludarabine)

Terminated
Has Results
  • Lymphocytic Leukemia, Chronic
  • Irkutsk, Russian Federation
  • +7 more
Nov 23, 2018

Lymphocytic Leukemia, Chronic Trial in Worldwide (Cyclophosphamide, Fludarabine, rituximab [MabThera])

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Buenos Aires, Argentina
  • +83 more
Nov 17, 2018

Rituximab (MabThera) in Chronic Lymphocytic Leukemia (CLL)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Frechen, Germany
    PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann
Dec 8, 2017

Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • San Diego, California
  • +261 more
Aug 15, 2018

Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • San Diego, California
  • +261 more
Aug 15, 2018

Lymphocytic Leukemia, Chronic Trial in Worldwide (obinutuzumab, rituximab, chlorambucil)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • San Diego, California
  • +261 more
Aug 15, 2018

Lymphocytic Leukemia, Chronic Trial in Belarus, Poland (Cladribine, Cyclophosphamide, Rituximab)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Minsk, Belarus
  • +5 more
Nov 17, 2017

Rituximab in Combination With Chemotherapy in CD20-Positive

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Alexandroupolis, Greece
  • +8 more
Apr 5, 2018

Lymphocytic Leukemia, Chronic Trial in Israel (Cyclophosphamide, Fludarabine, Rituximab)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Afula, Israel
  • +11 more
Apr 18, 2018

Lymphocytic Leukemia, Chronic Trial in Russian Federation (Cyclophosphamide, Fludarabine, Rituximab)

Terminated
Has Results
  • Lymphocytic Leukemia, Chronic
  • Irkutsk, Russian Federation
  • +9 more
Aug 22, 2017

Lymphocytic Leukemia, Chronic Trial in Austria (rituximab [MabThera/Rituxan], fludarabine, cyclophosphamide)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • rituximab [MabThera/Rituxan]
  • +2 more
  • Innsbruck, Austria
  • +7 more
Jul 11, 2017

Lymphocytic Leukemia, Chronic Trial in Italy (rituximab [MabThera/Rituxan], chlorambucil)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Catanzaro, Calabria, Italy
  • +19 more
Jul 6, 2017

Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute Trial in Saint Louis (AMD3100, Stem

Completed
Has Results
  • Leukemia, Myeloid, Acute
  • +7 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 5, 2017

Lymphocytic Leukemia, Chronic Trial in United States (Obinutuzumab, Corticosteroids)

Completed
Has Results
  • Lymphocytic Leukemia, Chronic
  • Birmingham, Alabama
  • +30 more
Mar 20, 2017

MabThera/Rituxan in Relapsing or Refractory Chronic Lymphocytic

Completed
  • Lymphocytic Leukemia, Chronic
    • Aix En Provence, France
    • +83 more
    Mar 21, 2017

    Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade Trial in Ann Arbor (Reduced intensity conditioning, Rapid

    Completed
    Has Results
    • Multiple Myeloma
    • +2 more
    • Reduced intensity conditioning
    • +2 more
    • Ann Arbor, Michigan
      The University of Michigan
    Jan 18, 2017

    Lymphoma, Small Lymphocytic, Lymphocytic Leukemia, Chronic Trial in Columbus (Fludarabine, Rituximab, Alemtuzumab)

    Completed
    • Lymphoma, Small Lymphocytic
    • Lymphocytic Leukemia, Chronic
    • Columbus, Ohio
      Ohio State University
    Feb 6, 2017

    Lymphocytic Leukemia, Chronic Trial in United States (Fludarabine, Obinutuzumab, Bendamustine)

    Completed
    Has Results
    • Lymphocytic Leukemia, Chronic
    • Huntsville, Alabama
    • +17 more
    Dec 8, 2016

    The Health Related Quality of Life in Chronic Lymphocytic

    Completed
    • Lymphocytic Leukemia, Chronic
      • Bournemouth, United Kingdom
      • +4 more
      Nov 1, 2016

      MabThera/Rituxan in Combination With Chemotherapy in B

      Completed
      • Lymphocytic Leukemia, Chronic
      • Vitoria, Alava, Spain
      • +54 more
      Nov 1, 2016